在V-A ECMO支持期间,新生儿肝功能衰竭早期发病的B组链球菌性败血症成功使用Jafron卡特里奇输血治疗V-A ECMO支持期间
Elisa Barberi1, Giacomo Bianchi2, Vitali Pak3
1Department of Anesthesia and Critical Care, Ospedale del Cuore, Fondazione Monasterio, Massa, Italy.
Perfusion
|March 2, 2026
概括
这项研究表明,血液吸收疗法可以有效地减少新生儿因败血症而接受体外膜氧化 (ECMO) 的严重高白血症. 这种创新方法为治疗重症婴儿肝衰竭提供了一个有前途的选择.
科学领域:
- 新生儿医学 新生儿医学
- 关键的护理关键的护理
- 生物医学工程 生物医学工程
背景情况:
- 新生儿败血症,特别是B组链球菌 (GBS) 败血症,可能导致多器官衰竭.
- 对于需要体外膜氧化 (ECMO) 的严重病例,传统治疗可能不足.
- 肝功能障碍与严重的高白血是新生儿ECMO期间的潜在并发症.
研究的目的:
- 在ECMO期间报告GBS败血症和肝功能衰竭的新生儿在血液吸收疗法的成功应用.
- 在这种情况下,评估Jafron HA60血液吸收盒在降低高 bilirubinemia 的有效性.
主要方法:
- 一个患有GBS败血症和败血性休克的新生儿在静脉动脉ECMO (V-A ECMO) 上开始治疗.
- 在ECMO电路中集成了一个Jafron HA60血液吸附卡片,以管理严重的高胆血症.
- 监测了患者的结局,包括胆红素水平和临床康复.
主要成果:
- 血液吸收疗法在24小时内使 bilirubin 水平降低了38%.
- 新生儿在15天后成功从ECMO中脱,并在24天后被抽管.
- 患者在48天后出院,神经学结果正常,尽管有诸如肺癌和功能障碍等并发症.
结论:
- 血液吸附技术是一种可行的辅助治疗方法,用于管理ECMO治疗新生儿的肝衰竭和严重的高白血症.
- 这一案例证明了血吸吸血的潜力,可以改善患有复杂并发症的重症新生儿的治疗结果.
相关概念视频
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
294
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
294
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
289
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
289
Acute Respiratory Failure-IV
627
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
627
Continuous Renal Replacement Therapy
1.4K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.4K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
687
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
687
Acute Respiratory Failure-V
554
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
554


